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ABSTRACT By using oligonucleotide-directed saturation
mutagenesis, we collected 366 different single amino acid sub-
stitutions in a 109-aa segment (residues 95–203) in the fingers
and palm subdomains of the HIV-1 reverse transcriptase (RT),
the enzyme that replicates the viral genome. After expression in
Escherichia coli, two phenotypic assays were performed. The first
assay tested for RNA-dependent DNA polymerase activity. The
other assay used Western blot analysis to estimate the stability
of each mutant protein by measuring the processing of the RT
into its mature heterodimeric form, consisting of a 66-kDa
subunit and a 51-kDa subunit. The resulting phenotypic data
provided a ‘‘genetic’’ means to identify amino acid side chains
that are important for protein function or stability, as well as side
chains located on the protein surface. Several HIV-1 RT crystal
structures were used to evaluate the mutational analysis. Our
genetic map correlates well with the crystal structures. Combin-
ing our phenotype data with crystallographic data allowed us to
study the genetically defined critical residues. The important
functional residues are found near the enzyme active site. Many
residues important for the stability of the RT participate in
potential hydrogen bonding or hydrophobic interactions in the
protein interior. In addition to providing a better understanding
of the HIV-1 RT, this work demonstrates the utility of saturation
mutagenesis to study the function, structure, and stability of
proteins in general. This strategy should be useful for studying
proteins for which no crystallographic data are available.
The development of oligonucleotide-directed mutagenesis (1)
enhanced the power of genetic analysis by providing a method to
introduce a mutation at a specific position in a DNA sequence.
This technique may be used to make a specific amino acid
substitution in a protein by altering codons. An adaptation of
site-specific mutagenesis led to saturation mutagenesis (reviewed
in ref. 2), which provides an approach to make libraries contain-
ing a collection of mutations at every base in a DNA element (3)
or at every amino acid in a protein (4).
X-ray crystallography is a powerful tool for studying protein
function and structure. However, the use of this method is
limited to proteins that crystallize. With the constant discovery
of new proteins with biological and medical importance,
additional methods that provide functional and structural
information are extremely valuable. In this study, we assess the
potential of saturation mutagenesis for the study of function
and stability of proteins for which structural data are difficult
to obtain, and as a means to offer additional insight into
proteins whose structures are known. By using saturation
mutagenesis we collected 366 unique single missense mutants
in a 109-aa region (residues P95 through E203) in the fingers
and palm subdomains of the HIV-1 reverse transcriptase (RT).
The HIV-1 RT is encoded by the viral pol gene, which
contains the coding sequences for the protease, RT (with both
DNA polymerase and ribonuclease H activities), and inte-
grase. We previously developed a bacterial expression system
for the HIV-1 pol gene (5, 6) (Fig. 1). In this system the pol
gene products are expressed initially as a 120-kDa polypeptide
that is processed by the viral protease to produce the mature
protease (11 kDa), RT (66-kDa and 51-kDa heterodimer), and
integrase (34 kDa). This process appears indistinguishable
from protease processing in the virus.
The wild-type RT expressed in our system is catalytically
active. We have two biological assays to test the effect of RT
mutations. The first assay is an in vitro RNA-dependent DNA
polymerase assay to test for the enzymatic activity of the RT.
Mutations at amino acid residues involved either directly or
indirectly in enzyme catalysis will result in loss of RT activity.
Alternatively, loss of RT activity may be caused by a mutation
at a residue involved in the protein stability of the RT. In our
second phenotype assay, we used Western blot analysis to
estimate the stability of each mutant by measuring the pro-
cessing of the RT into its mature heterodimeric form. There is
an equilibrium between the catalytically inactive denatured
state and the native state where the protein is correctly folded
in its biologically active conformation (7). Destabilizing mu-
tations shift the equilibrium toward the unfolded state. Un-
stable proteins sometimes aggregate and become insoluble,
which can interfere with normal processing. Furthermore, an
unstable protein may become accessible to cellular proteases
and be degraded. Our Western blot analysis shows the amounts
of correctly processed protein, as well as unprocessed precur-
sor or improperly processed products. We also used Western
blots to determine the relative amount of soluble protein.
Combining the RT activity and Western blot phenotype data
for all our mutants, we constructed a genetic map of the HIV-1
RT that predicts the residues involved in protein function and
stability, as well as which side chains are on the protein surface.
We then compared our predictions with crystallographic data to
demonstrate the utility of saturation mutagenesis as a method for
gaining insight into both protein function and structure.
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RT Expression System. The HIV-1 RT expression plasmid
is pART1E66M (pE66M) (8). In pE66M (Fig. 1) the pol gene
is under the control of the inducible lac promoter. This vector
is a phagemid, with origins of replication to allow propagation
as a plasmid or as a single-stranded DNA phage.
Mutant Library Construction. By using an improved oligo-
nucleotide-directed saturation mutagenesis strategy, a 326-bp
region of the HIV-1 RT spanning amino acid residues P95
through E203 was randomly mutagenized (8, 9). This process
was accomplished through the production of 11 mutant librar-
ies (labeled L, M, N, O, P, Q, R, S, T, U, and V) (Fig. 1). These
libraries were stored as phagemid stocks. An additional 21
mutants were made by using site-directed mutagenesis to fill
gaps. We made nine more site-specific mutants (T107S,
T107V, V118T, L120A, L120T, T128V, Y146F, S191T, and
H198Q) to study the role of certain residues in more detail.
Initial Genotype Screening. Escherichia coli strain JM101
was infected with each phagemid library and plated onto 23
YT (1.0% tryptoney1.0% yeast extracty0.5% NaCl) ampicillin
plates. Individual clones were randomly picked from the plates
and inoculated into 23 YT liquid medium [supplemented with
200 mgyml of ampicillin, 10 mgyml of thiamine, 0.2% glucose,
and M13KO7 helper phage (10) or VCSM13 helper phage
(Stratagene)]. The cultures were grown for 12–18 hr at 37°C,
then pelleted by centrifugation and two aliquots of the phage
supernatant were removed: an 800-ml aliquot (for single-
stranded DNA isolation) and a 150-ml aliquot (a phage stock
for long-term storage of each mutant). The single-stranded
DNA was isolated from the phage particles by using a NaI
method (11), a QIAprep Spin M13 Kit (Qiagen), or as
described previously (6). The region spanning the site of
mutagenesis in each clone was sequenced according to the
manufacturer’s protocol for the Sequenase version 2.0 DNA
sequencing kit (United States Biochemical) or with the Kle-
now fragment of E. coli DNA polymerase. The resulting clones
contained 0, 1, or more nucleotide substitutions. Clones with
a nucleotide substitution(s) resulting in a single missense
mutation were subjected to phenotype assays.
Preparing Lysates for Phenotype Analysis. RT mutant
phagemid clones were infected into E. coli strain JM101 and
plated onto glucose-minimal-ampicillin plates. Individual col-
onies were inoculated into two separate cultures: 23 YT
(supplemented as described above) to confirm the mutant’s
genotype and M9 minimal medium (without glucose and
supplemented with 0.4% casamino acids, 0.001% thiamine,
and 200 mgyml of ampicillin) to determine the phenotype. The
genotype cultures were processed as described above. The
phenotype cultures were grown at 37°C to an optical density of
0.2–0.4 at 600 nm, adjusted to equal concentrations of cells,
and induced with 1 mM or 5 mM isopropyl-b-D-thiogalacto-
pyranoside at 37°C for 2 hr. Each culture then was used to
prepare lysates for the assay of RT activity (8) and Western
analysis (6). Lysates of the soluble fraction to be used for
Western blot analysis were prepared by adding 15 ml of 43
sample buffer (63 mM Tris, pH 6.8y2% SDSy10% glyceroly5%
b-mercaptoethanoly1 mg/ml bromophenol blue) to 30 ml of the
lysate made for the RT activity assay.
Phenotype Assays. The RT activity was assayed by using a
poly(rC)-oligo(dG) template-primer as previously described
(8). RT activity for each mutant was expressed as a percentage
of RT activity of the wild-type clone (pE66M). Western blot
analysis of total cell lysates and soluble lysates was performed
as described previously (6), with the exception that for mutants
of residues P95 through M164 the blots were stained with the
NEA-9304 mouse monoclonal anti-HIV-1 RT antibody (Du-
Pont) instead of a polyclonal anti-HIV-1 RT antibody.
Computer Analysis of Crystal Structures. The crystal struc-
ture viewing program Kinimage version 4.2 (12) was used to
analyze the mutant phenotypes, build models, and find inter-
atomic distances. The computer program RIBBONS (13) was
used to create the crystal structure figures. The coordinates of
the crystal structures used in the analyses were obtained from
the Brookhaven Protein Data Bank [1har (14), 1rtj (15), 1hmi
(16), and 1mml (17)].
Sequence Variability Calculation. An alignment of 29 ret-
roviral RT sequences (18) was used to calculate the variability
of each residue position (P95 through E203 in HIV-1 RT).
Variability is defined at each position as the number of
different residues found at that position divided by the fre-
quency of the most common residue (19). Variability is
calculated as v 5 dy(mys) 5 dsym, where d is the number of
different residues found at that position, m is the number of
occurrences of the most frequent residue at that position, and
s is 29, the number of sequences in the alignment. At a few
positions where gaps were introduced into some sequences to
produce the best alignment, the gap has been treated as one
type of residue for the purposes of the calculation. For
FIG. 1. pE66M HIV-1 RT expression vector. The HIV-1 RT
expression vector pE66M contains the entire HIV-1 pol gene cloned
into the phagemid pIBI20 (IBI). The pol gene is under control of the
inducible lac promoter. The 11 mutant libraries (L through V) are
contained in the BamHI–SacI cassette. This figure is not drawn to
scale.
FIG. 2. Examples of Western blot analysis of HIV-1 RT mutants.
Western blot analysis demonstrating the four phenotypes for total cell
lysates (wild type, US, UL, and Lt) and the four phenotypes for soluble
lysates (wild type, faint, very faint, and no bands). The Western
phenotypes are described in Results and Discussion. The Western blot
is stained with a monoclonal anti-HIV-1 RT antibody. p66 and p51 are
the subunits of the mature heterodimeric HIV-1 RT. Samples in lanes
1–7 are total cell lysates: 1) V111G (wild-type phenotype); 2) Y144F
(US phenotype); 3) pE66M (a wild-type HIV-1 RT clone); 4) P133A
(Lt phenotype); 5) L149R (Lt phenotype); 6) A129G (Lt phenotype);
7) Y146D (UL phenotype). Samples in lanes 8–12 are soluble lysates:
8) pE66M (a wild-type HIV-1 RT clone); 9) P133A (very faint
phenotype); 10) L149R (no bands phenotype); 11) A129G (faint
phenotype); 12) Y146D (no bands phenotype).






















FIG. 3. Summary and analysis of HIV-1 RT mutant phenotypes. Phenotypes of single missense mutations in a 109-aa region of the HIV-1 RT.
Mutants were isolated from 11 overlapping random substitution libraries designated L, M, N, O, P, Q, R, S, T, U, and V. The region mutagenized
in each library is indicated by a horizontal dashed line. The secondary structural elements indicated are from the 3hvt HIV-1 RT crystal structure
(24) and not from the 1rtj crystal structure (15), which is shown in Fig. 5. There are minor differences between them with respect to the end points
assigned for a helices and b strands. The conservative amino acids are grouped as follows: (A, S, T, G, P); (V, L, I, M); (R, K, H); (D, E, N, Q);






















example, an invariant residue among all 29 retroviral RTs
would have a variability of one.
Molecular Surface Area (MSA) Calculation. An MSA anal-
ysis was performed on the HIV-1 RT crystal structure 1rtj (15)
by using the program GEPOL (20, 21) to determine the exposed
MSA for every atom in the HIV-1 RT heterodimer. The sum
of the MSA of side-chain atoms for each residue was calculated
to give the exposed MSA for amino acids in the fingers and
palm subdomains for the 66-kDa subunit (22). The buried
MSA was calculated by subtracting the exposed MSA for each
residue from the MSA of the amino acid side chain in the
second position in an alanine-X-alanine tripeptide by using
MSAs compiled in ref. 23.
RESULTS AND DISCUSSION
Collection of Single Amino Acid Substitutions. By sequenc-
ing individual clones from our 11 mutant libraries spanning
HIV-1 RT residues P95 through E203, we identified 336
unique single missense mutations. We constructed an addi-
tional 30 mutations by using site-directed mutagenesis. A
survey of the literature revealed 258 unique single amino acid
replacements isolated by others in the entire HIV-1 RT (22).
Of these replacements, 99 mutations representing 48 different
sites are in the region of our cassette, but only 33 are common
to our collection. These mutations are found in either HIV-1
RT clones or in viral isolates.
Interpretation of Phenotype Data. RT assay.We tested each
mutant for RNA-dependent DNA polymerase activity by
performing an in vitro RNA-dependent DNA polymerase
assay using a crude lysate of bacteria expressing each mutant.
RT activity is expressed as a percentage of the activity
obtained from the wild-type clone pE66M. The results are
divided into four categories: negative (,3% of wild-type
activity), low intermediate ($3% but ,20% of wild-type
activity), high intermediate ($20% but ,50% of wild-type
activity), and wild-type or positive ($50% of wild-type activ-
ity).
Western blot analysis. Because our system expresses the
entire HIV-1 pol gene, we are able to use Western blot analysis
to measure protease processing of the RT into its mature
heterodimeric form. On a Western blot of wild-type RT, we
detect a 66-kDa band (p66) and a 51-kDa band (p51), repre-
senting the two subunits of the active RT. Abnormal process-
ing is assumed to result from protein stability changes, because
the processing cleavage sites are outside the mutagenic region.
Mutations affecting processing could result in the aggregation
of the mutant protein (leading to incomplete processing) or
proteolytic degradation (causing loss of signal). Examples of
Western blot phenotypes of HIV-1 RT mutants are shown in
Fig. 2.
We obtained Western blots for both soluble fraction lysates
and total cell lysates. In interpreting the Western blot data, we
classified the phenotype for individual mutants as either
positive or negative for protein stability. A specific mutant was
considered positive for protein stability if either the total cell
lysate or the soluble lysate gave a wild-type phenotype. A
specific mutant was considered to be negative for protein
stability if the total cell lysate gave a non-wild-type phenotype
and, if determined, a non-wild-type phenotype for soluble
lysates.
The results for the Western blot analysis of the soluble
lysates are classified as ‘‘wild-type’’ for the presence of wild-
type levels of the p66 and p51 forms of the mature RT, ‘‘faint’’
for reduced levels of p66 and p51, ‘‘very faint’’ for a further
reduction of p66 and p51 when compared with those in the
faint category, and ‘‘no bands’’ for the complete absence of p66
and p51.
The results for the total cell lysates for libraries S, T, U, and
V (M164–E203) were described previously (8). The pheno-
types for mutants in these libraries were classified as wild type
or positive for efficient processing to produce stable products,
as indicated by the presence of wild-type levels of p66 and p51
forms of the mature RT, negative for inefficient processing,
indicated by the near absence of p51, along with a much
reduced level of p66, with some high and low molecular weight
products when compared with a wild-type clone, and inter-
mediate for a variety of phenotypes, generally indicated by a
reduced level of the RT heterodimer.
The phenotypes as measured by Western blot analysis for
mutants in libraries L, M, N, O, P, Q, and R (residues
P95–M164) for total cell lysates are classified as wild type for
the presence of wild-type levels of the p66 and p51 forms of the
mature RT with no unprocessed high molecular weight bands;
upper strong (US) for the presence of wild-type levels (strong)
of the p66 and p51 forms of the mature RT with unprocessed
high molecular weight (upper) bands; upper light (UL) for the
presence of reduced levels (light) of the p66 and p51 forms of
the mature RT with unprocessed high molecular weight (up-
per) bands; and light (Lt) for the presence of reduced levels
(light) of p66 and p51 forms of the mature RT with no
unprocessed high molecular weight bands. These unprocessed
high molecular weight bands are insoluble, because they are
absent in Western blots of the soluble lysates.
Genetic Classification of HIV-1 RT Residues. By using the
collection of RT activity and Western blot data for the 366
mutants, we produced a genetic map of critical residues within
the HIV-1 RT (Fig. 3). Fig. 4 describes our classification of
individual amino acid residues with respect to their roles in the
protein. This approach works well with a few mutations at a
particular residue, although our classification system is not
absolute. Occasionally, when there are many substitutions at a
particular residue, exceptions are observed and the site is
(F, Y, W); (C) (25). RT phenotypes are expressed as follows: uppercase 5 wild-type or positive; italicized uppercase 5 high intermediate; italicized
lowercase 5 low intermediate; lowercase 5 negative. In the line labeled ‘‘RT sensitivity pattern,’’ those residues that are mutationally insensitive
for RT activity are indicated by X; those residues that have extreme mutational sensitivity for RT activity are indicated by O; those residues that
have extreme mutational sensitivity for RT activity with nonconservative substitutions, but not with conservative substitutions, are indicated by
Z. The RT and Western sensitivity patterns are defined in Fig. 4. The phenotypes from Western blots of total cell lysates for residues P95 to M164
are expressed as follows: uppercase 5 wild type; italicized uppercase 5 US; italicized lowercase 5 UL; lowercase 5 Lt. The phenotypes from
Western blots of total cell lysates for residues M164 to E203 are expressed as follows: uppercase 5 wild type; italicized uppercase 5 intermediate;
lowercase 5 negative. The phenotypes from Western blots of soluble lysates are expressed as follows: red 5 wild type; green 5 faint; purple 5
very faint; cyan 5 no bands; black 5 not determined. In the line labeled ‘‘Western sensitivity pattern,’’ those residues that are mutationally insensitive
for protein stability are indicated by X; those residues that have extreme mutational sensitivity for protein stability are indicated by O; those residues
that have extreme mutational sensitivity for protein stability with nonconservative substitutions, but not with conservative substitutions, are
indicated by Z. Roles of key residues are designated as follows: F 5 functionally important; C 5 catalytically important; S 5 important for protein
stability (conservative interpretation); s 5 additional residues important for protein stability from a liberal interpretation; E 5 external. The roles
indicated were those assigned before we made additional substitutions to study residues critical for stability in more detail. These mutants (T107S,
T107V, V118T, L120A, L120T, T128V, Y146F, S191T, and H198Q) are underlined, and their phenotypes were not used to establish the sensitivity
patterns. A table listing the data used to assemble this figure can be viewed at www.unc.eduy;clyde. This table includes the actual percent RT
activity for each HIV-1 RT mutant.






















classified according to the preponderance of the data (see
discussion below).
Positions at which all mutations have wild-type character-
istics for both RT activity and protein stability as measured by
Western blot analysis are classified as ‘‘external.’’ External side
chains are not in contact with other critical residues or
substrate and are expected generally to be insensitive to
substitutions. In our scheme, mutations resulting in wild-type
RT activity, along with wild-type levels of mature RT in both
total cell and soluble lysates, and with only small amounts of
unprocessed product in total cell lysate, are classified as wild
type for stability (e.g., K103T).
Catalytic residues are defined as those at positions where all
substitutions, both conservative and nonconservative, result in
proteins that are negative for RT activity and have wild-type
Western phenotypes. Functional residues are defined as those
in which all nonconservative changes result in mutant proteins
that are negative for RT activity, but where conservative
changes are not all negative for RT activity. All changes in
functional residues have wild-type phenotypes for protein
stability. For residues with four or more substitutions, we
allowed one mutation to deviate from the strict rules for
functionalycatalytic classification by one phenotype category
(i.e., low intermediate category for RT activity or intermediate
or US category for Western blot analysis). These residues
include: D185 (classified as catalytic although D185V gives an
intermediate Western phenotype), M184 (classified as func-
tional although M184V gives an intermediate Western phe-
notype), Y183 (classified as functional although Y183C has 5%
of wild-type RT activity), and G99 (classified as functional
although G99L gave a US Western phenotype).
Residues important for stability are defined as those in
which every nonconservative change (and in some cases some
of the conservative substitutions) resulted in RTs with non-
wild-type Westerns (for both total cell lysates and soluble
lysates) and negative RT activity less than 3% (conservative
interpretation) and low intermediate RT activity less than 20%
(liberal interpretation). After initial identification of residues
potentially involved in stability, we made additional site-
directed substitutions at some of these positions (T107S,
T107V, V118T, L120A, L120T, T128V, Y146F, S191T, and
H198Q) to study their role in stability in more detail. Data
from these new mutations sometimes altered our initial clas-
sification.
Evaluation of the Genetic Map of Critical Residues in HIV-1
RT. Visual inspection of crystal structures. Because the HIV-1
RT is a heterodimer consisting of 66-kDa and 51-kDa subunits
resulting from different processing of the same polypeptide
sequence, a mutation made at a specific amino acid residue will
be present in both subunits. The observed phenotype from a
particular amino acid substitution will result from the change
in the 66-kDa subunit, the 51-kDa subunit, or both. Fig. 5
shows the placement of the functionalycatalytic, stability, and
external residue side chains on the fingers and palm subdo-
mains of the 66-kDa subunit in the HIV-1 RT crystal structure
1rtj (15). The 66-kDa subunit plays the major role in enzyme
catalysis. As expected, most of the functionalycatalytic resi-
dues cluster around the active site in the DNA binding cleft.
Generally, the protein stability side chains face the interior of
the protein, and the external side chains point away from the
surface. We also analyzed the placement of important residues
by using the crystal structure 1hmi (16) complexed with DNA.
The functionalycatalytic residues are located near the DNA
template-primer (data not shown). Because this structure lacks
side chains, we are unable to analyze the interaction of the
functionalycatalytic residues with the DNA template-primer.
Residue variability among other retroviral RTs. Residues
involved in protein functionycatalysis and stability are ex-
pected to be conserved among other retroviral RTs. On the
other hand, external residues are expected to be highly vari-
able. To test this hypothesis, by using a sequence alignment of
29 retroviral RTs (18) we calculated the variability for HIV-1
RT residues P95 through E203. As expected most of the
external residues are highly variable, whereas the functionaly
catalytic and stability residues are conserved (22).
MSA analysis. Stability residue side chains should be buried,
whereas external residue side chains should be exposed on the
surface. Functionalycatalytic side chains also should be ex-
posed to be in a position to interact with substrate. To test this
hypothesis, we calculated the actual MSA buried and the
percent MSA buried for amino acids in the fingers and palm
subdomains of the 66-kDa subunit and the 51-kDa subunit.
Sorting the residues in order of percent MSA buried shows
that, in general, the stability residues have higher percentages
of MSA buried compared with the functionalycatalytic and
external residues (22).
Variability versus MSA. A scatter graph plotting variability
versus percent MSA buried was used to further evaluate the
genetic map for the 66-kDa subunit (Fig. 6). In theory, the
external residues should fall in the upper-left portion of the
graph (high variability and low side-chain burial), the catalyt-
icyfunctional residues should fall in the lower-left portion of
the graph (low variability and low side-chain burial), and the
residues important for protein stability should fall in the
lower-right portion of the graph (low variability and high
side-chain burial). As seen in the graph, our genetic classifi-
cation of the residues fits these predictions quite well for the
66-kDa subunit. Similar results were obtained for the 51-kDa
subunit, with the exception that most of the catalyticy
functional residues were more buried (22).
FIG. 4. Significance of mutational sensitivity patterns. Positions
that show theoretical mutational patterns of extreme sensitivity (2),
sensitivity to nonconservative changes (1y2), or insensitivity (1), for
the two assays identify different classes of significant residues. Extreme
sensitivity for RT assay data occurs when all mutations, both conser-
vative and nonconservative, result in RT activity less than 3%.
Sensitivity to nonconservative changes for RT assay data occurs when
all nonconservative changes, but not all conservative changes, have less
than 3% RT activity. Insensitivity for RT assay data occurs when all
mutations, both conservative and nonconservative, result in wild-type
levels of RT activity. Extreme sensitivity from Western blot analysis
occurs when all mutations, both conservative and nonconservative, are
negative [where the total cell lysate has a non-wild-type phenotype
(US, UL, Lt, intermediate, or negative phenotype) and, if determined,
a non-wild-type phenotype (faint, very faint, or no bands) for soluble
lysates]. Sensitivity to nonconservative changes from Western blot
analysis occurs when all nonconservative changes, but not all conser-
vative changes, have a negative phenotype. Insensitivity from Western
blot analysis is where all mutations, both conservative and noncon-
servative, are positive (where either the total cell lysate or the soluble
lysate has a wild-type phenotype). E indicates the pattern expected for
external residues. S indicates residues important for protein stability.
C and F designate residues of catalytic and functional importance.
Classes indicated by (X) are expected to be empty.






















A few of the residues do not fall within their predicted region
in the variability versus percent MSA buried scatter graph.
These residues are indicated on the scatter graph for the
66-kDa subunit in Fig. 6. Functional residues that play an
indirect role by maintaining the local conformation for other
functional residues that interact directly with substrate are
expected to be conserved and buried and appear in the
lower-right portion of the graph. S156, a functional residue
that is conserved but buried, plays an indirect role in RT
function. We propose that S156 helps determine the confor-
mation of the b8-aE loop in the 66-kDa subunit. A noncon-
servative substitution (S156L) here may alter the local con-
formation of the loop and thus interfere with RT function, but
does not appear to disrupt the overall stability. This loop
interacts with substrate (17, 26). Another functional residue
that is conserved but buried, A114, lies in a region believed to
be involved in template-primer binding (27). A valine substi-
tution at residue A114, has negative RT activity, without
affecting stability. It is possible that the larger and more bulky
hydrophobic valine substitution interferes indirectly with tem-
plate-primer binding. Although less buried and less conserved
than A114, S117 (another functional residue exception) also is
located in this template-primer binding region.
Two residues important for protein stability (F130 and I202)
fall outside of the predicted region in the plot of variability
versus percent MSA buried (Fig. 6). The side chain of I202 has
a greater variability but a percent molecular surface area
buried similar to other stability residues. From inspection of
the crystal structure 1rtj for the HIV-1 RT (15), I202 appears
to be involved in a stabilizing van der Waals interaction
(unpublished observation). Likewise, an inspection of the
crystal structure 1mml for the murine leukemia virus RT (17)
reveals that T240 (the equivalent of I202 in HIV-1 RT) may be
involved in a stabilizing hydrogen-bonding interaction (unpub-
lished observation). The higher variability of residue I202
appears to result from the ability of a residue at that position
to stabilize the protein by at least two different mechanisms.
In contrast to I202, F130 is invariant in the sequence alignment
of 29 retroviral RTs (18), but is more exposed than other
residues involved in protein stability. Although more exposed,
all of the side-chain atoms of F130, except for carbons Cb and
Cg, are in van der Waals contacts with carbon atoms of other
hydrophobic side chains in the 66-kDa subunit. These van der
Waals interactions most likely are important for protein
stability. Furthermore, F130 is more buried in the 51-kDa
subunit and all of its side-chain atoms are in van der Waals
contacts with carbon atoms of other hydrophobic side chains
(22).
The variability calculated for one external residue, Q197, is
unusually low. However, the value of molecular surface area
buried for this residue is typical of external residues. Only nine
of the 29 aligned RT sequences have an amino acid at this
FIG. 5. Stereo view of critical residues of the HIV-1 RT. The polypeptide backbone of the fingers and palm subdomains of the 66-kDa subunit
of the HIV-1 RT from the 1rtj crystal structure (15) is shown. The polypeptide backbone of the region we mutagenized (residues P95 through E203)
is colored in yellow. Side chains for critical residues are colored as follows: catalytic (D110, D185, and D186) in purple, functional in cyan, stability
(from a conservative interpretation of the mutational data) in red, and external in green. This figure was generated by using the program RIBBONS
(13).






















position in the alignment (20 are gapped) (18). The available
sequences probably do not adequately sample the potential
variability at position 197, and the variability calculation used
here (19) is not designed to deal with this situation.
External residues. External residues are expected to be
hydrophilic to interact with solvent water. Consistent with this
expectation, most (7 of 10) of the external residues are
hydrophilic with the exception of V106, I142, and I195. The
sequence variability and MSA analyses support our genetic
classification of the two hydrophobic residues I142 and I195 as
external. I142 has a high variability and a percent MSA buried
of 5% in the 66-kDa subunit and 23% in the 51-kDa subunit,
whereas I195 also has a high sequence variability and a percent
MSA buried of 2% in the 66-kDa subunit and 8% in the 51-kDa
subunit. V106 also has a high sequence variability, although it
is more buried than the other external residues. One interest-
ing observation is that mutations at four of the external
residues (K101, K103, V106, and E138) result in HIV-1 RT
resistance to various non-nucleoside inhibitors (28, 29).
Functional residues. We were able to identify D110, D185,
and D186 as catalytically important. These three residues
comprise the evolutionarily conserved aspartic acid triad of the
active site of RT. All of the functionalycatalytic residues in the
66-kDa subunit of the 1hmi crystal structure are located near
the template-primer substrate, except for N136 and P140,
which both are part of the b-b loop (shown in Fig. 5 for the 1rtj
crystal structure). N136 and P140 in the 51-kDa subunit are
located near the DNA substrate, suggesting their functional
role is realized through the smaller subunit.
Protein stability residues. Several regions are important for
stability: F124–P133, R143–P150, I167–E169, and L187–S191.
Both hydrophobic and hydrophilic residues are classified as
important for protein stability. We have combined crystal
structure analysis with our mutational data to propose hydro-
gen bonding and hydrophobic stabilizing interactions for many
of the residues important for protein stability (unpublished
work). An example of this approach is described in the next
section.
T107yS191yH198 interaction. Three hydrophilic stability res-
idues (T107, S191, and H198) are within hydrogen bonding
distances of one another. In the two highest resolution HIV-1
RT structures, 1har (2.2 Å) (14) and 1rtj (2.35 Å) (15), the
side-chain oxygen of S191 is within hydrogen bonding distance
of the Nd1 nitrogen of H198, whereas the side-chain oxygen of
another residue T107 is within hydrogen bonding distance of
the N«2 nitrogen of H198. In the 1har structure, the distance
between S191 Og and H198 Nd1 is 2.7 Å, and the distance
between T107 Og1 and H198 N«2 is 2.8 Å. In this model, H198
forms two hydrogen bonds, one with S191 and another with
T107. These potential hydrogen bonds appear significant
because they bring together aF, b6, and b10. The aspartic acids
of the catalytic triad (D110, D185, and D186) are in b6, b10,
and the loop joining b10 and b9. This interaction can be viewed
in Fig. 7.
Mutations at H198 and S191 clearly establish the impor-
tance of hydrogen bonding in protein stability. Replacing S191
with nonpolar side chains (alanine and phenylalanine) that
cannot hydrogen-bond disrupts protein stability. An alanine
side chain is identical to that of serine, except for the presence
of a hydroxyl group on the serine with hydrogen bonding
potential. Although a tyrosine substitution also abolishes
stability, the tyrosine side chain may be too bulky to properly
hydrogen-bond with H198. A threonine replacement at S191
has wild-type stability. Threonine has a small polar side chain
like serine and differs only in the addition of a methyl group.
FIG. 6. RT sequence variability vs. percent MSA buried for
residues P95 through E203 of the HIV-1 RT 66-kDa subunit. This
figure is a scatter graph plotting RT sequence variability (y axis)
against percent MSA buried (x axis) for HIV-1 RT residues P95
through E203. The percent MSA buried is for residues in the 66-kDa
subunit. Glycine residues are not included. Residues assigned a role
from an interpretation of the mutational data are designated as
follows: red ■ (stability), red h (additional stability residues from a
more liberal interpretation of the mutational data), cyan } (function-
alycatalytic), and green F (external). Unclassified residues are indi-
cated with black ‚. Residues that fall outside of their predicted region
are labeled with their sequence position (functional residues A114,
S117, and S156, stability residues F130 and I202, and the external
residue Q197).
FIG. 7. T107yS191yH198 hydrogen bonding interaction. Potential
hydrogen bonding interactions between T107 and H198 and between
S191 and H198 are shown. The polypeptide backbone is shown for
amino acid residues S105–D110 and D185–W212 from HIV-1 RT
crystal structure 1har (14). Secondary structural elements shown are
b6 (green), b10 (green), and aF (blue). Amino acid chains (T107,
D110, D185, D186, S191, and H198) are shown. Side-chain nitrogen
atoms are represented as purple dots, and side-chain oxygens as red
dots. In the crystal structure 1har, the atomic distance between T107
Og1 and H198 N«2 is 2.8 Å and between S191 Og and H198 Nd1 is
2.7 Å. Side chains D110, D185, and D186 (catalytic aspartic acid triad
of the active site) are included as a reference point. This structural
representation is approximately inverted compared with the one in
Fig. 5. This figure was generated by using the program RIBBONS (13).






















Substituting a proline at S191 most likely destabilizes the
protein by altering the configuration of the backbone. The role
of H198 seems to be quite specific. Replacing H198 with
another basic residue (arginine) disrupts stability. Other
changes with the polar side chains tyrosine and asparagine, as
well as a proline, also destroy protein stability. A glutamine
substitution partially restores stability. Glutamine is similar in
size to histidine and has two side-chain atoms that can form
hydrogen bonds. Some of the low-resolution HIV-1 RT crystal
structures do not have the S191 and H198 side chains posi-
tioned within hydrogen bonding distance in either subunit,
thus showing the usefulness of our mutational approach as a
method to evaluate the accuracy of certain crystal structures.
On the other hand, the T107-H198 hydrogen bond is not
essential for stability. Replacing T107 with an alanine, which
cannot form a hydrogen bond, does not affect stability. Be-
cause T107 is within hydrogen bonding distance of H198 it is
likely that they hydrogen-bond, but that this hydrogen bond is
not essential to protein stability. These hydrogen bonds (S191-
H198 and T107-H198) illustrate the use of mutational analysis
to differentiate between an interaction that is critical for
protein stability and one that is not.
Utility of Saturation Mutagenesis in the Study of Proteins.
This study demonstrates the usefulness of large-scale satura-
tion mutagenesis as a method for understanding protein
function and structure. Independent of crystallographic data,
we identified residues that are involved in protein function and
stability, in addition to residues with external side chains.
Subsequent analysis using the available crystal structures
reveals that our genetic map of critical residues within the RT
is quite accurate. This analysis illustrates the potential power
of saturation mutagenesis in the study of proteins for which no
crystal structure is available.
Even when structural information is available, as in the case
of the HIV-1 RT, it is difficult to infer the roles of specific
residues in protein function or stability directly from the
structure. In such cases saturation mutagenesis complements
the crystallographic data by providing biological evidence
concerning the roles of specific residues. In certain cases
mutational analysis may be used to test specific features of a
structural model or distinguish between alternative structures.
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